300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Andorra
Guernsey
Cameroon
Sudan
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Namibia
Malta
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Mozambique
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Qatar
Albania
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Spain
Angola
Europe
Cyprus
Peru
Slovenia
San Marino
Chile
Ukraine
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Hillhouse Capital, VC Fund

Hillhouse Capital

VC Fund

Zhuhai, China

Hillhouse Capital is an investment firm.

Total investments:
87
Last investment:
Lead investor:
43%

Last updated:

Industries Hillhouse Capital invests in

Artificial IntelligenceRoboticsManufacturingMedicalSoftware

Stages Hillhouse Capital invests in

SeedSeries ASeries BAngelSeries E

Countries Hillhouse Capital invests in

ChinaUnited StatesHong KongSingapore

Round sizes

Seed $10M–$100MSeries A $14M–$100MSeries B $42M–$149M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$10M–$100M
Series A
$14M–$100M
Series B
$42M–$149M

Investment Focus

Industry

  • Artificial Intelligence 8 (9%)
  • Robotics 7 (8%)
  • Manufacturing 4 (5%)
  • Medical 3 (3%)
  • Software 3 (3%)
See all 50 industries →

Stage

  • Seed 16 (18%)
  • Series A 8 (9%)
  • Series B 8 (9%)
  • Angel 2 (2%)
  • Series E 1 (1%)
See all 7 stages →

Country

  • China 27 (31%)
  • United States 4 (5%)
  • Hong Kong 1 (1%)
  • Singapore 1 (1%)

Team

NameTitleInvestmentsLinksEmail
Sean Carney
Sean Carney Partner & Co-Head of Global Buyout
Partner & Co-Head of Global Buyout Total investments: 1 Find email
Wang Bei Partner
Partner Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
Xingyue Semiconductor Xingyue Semiconductor
Xingyue Semiconductor designs, develops, and distributes integrated circuits and devices. $149M / Series B / Sep 04, 2026
Nova Fusion
Nova Fusion is an innovative company that provides commercialization of small modular nuclear fusion reactors. $178.5M / Seed / Aug 31, 2026
Convergen Convergen
Convergen develops TrimTAC, a targeted protein degradation platform for treating neurodegenerative diseases and other conditions driven by protein aggregates $15M / Seed / Aug 31, 2026
Miwei Technology focuses on the research and development of service-oriented intelligent computing systems, forming a product system centered on intelligent computing operating system + intelligent edge computing + intelligent cloud computing. $14.9M / Series A / Aug 31, 2026
Current Robotics develops next-generation intelligent systems and cross-embodiment world simulators to build intelligence for humanoid platforms. The company's core business model revolves around combining robotic research with practical engineering to enable machines to work safely alongside humans. Its primary value proposition is providinginteractive, controllable simulated environments that train and advance AI-driven robot policies. Seed / Aug 20, 2026
NK-Quantum is a quantum computing firm dedicated to the independent research, development, and engineering of underlying system architectures for neutral atom quantum computing. Seed / Aug 13, 2026
LatentVerse
LatentVerse develops a unified foundation model architecture combining vision-language models, world models, and real-time tactile feedback to enable robots to understand task intent and physically navigate unstructured environments. Seed / Aug 11, 2026
Qisuan Kuang-Chi is a pioneering artificial intelligence hardware company focusing on the research, development, and engineering of AI optical computing chips and related system infrastructure. The company utilizes a proprietary all-optical interference technology architecture to bypass physical constraints found in legacy electronic chipsets,aiming to establish computational infrastructure for Artificial General Intelligence (AGI). Angel / Aug 10, 2026
Liobate specializes in designing, creating, and selling thin-film lithium niobate modulator chips and related optical interconnect devices. Series B / Aug 06, 2026
AsymBio is a biopharmaceutical contract development and manufacturing organization focused on biologics and bioconjugates. It provides integrated services spanning R&D, developability assessment, process optimization, CMC, analytical science, quality control, regulatory affairs, and cGMP manufacturing. The company specializes in antibodies,recombinant biotherapeutics, antibody-drug conjugates and other novel drug conjugates, bioconjugates, and mRNA. AsymBio supports programs from early-stage development through late-stage clinical and commercial production using single-use bioreactors, fill-finish lines, and large-scale manufacturing bases. $183.6M / Private Equity / Aug 04, 2026
See all 87 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Andorra
Guernsey
Cameroon
Sudan
Colombia
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Namibia
Malta
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Mozambique
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Qatar
Albania
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Spain
Angola
Europe
Cyprus
Peru
Slovenia
San Marino
Chile
Ukraine
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Hillhouse Capital invest in?

Hillhouse Capital invests primarily in Artificial Intelligence, Robotics and Manufacturing startups, most often at Seed and Series A stage. Most of the 87 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Hillhouse Capital's check size?

Hillhouse Capital typically joins rounds of $10M–$100M at Seed, $14M–$100M at Series A and $42M–$149M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hillhouse Capital participates in.

How do I contact Hillhouse Capital?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Hillhouse Capital?

The team at Hillhouse Capital includes Sean Carney (Partner & Co-Head of Global Buyout) and Wang Bei (Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Hillhouse Capital Hillhouse Capital Find emails